- Home
- PCRX vs LOMA Comparison
PCRX vs LOMA Comparison
Compare PCRX & LOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCRX | LOMA |
|---|---|---|
| Founded | 2006 | 1926 |
| Country | United States | Argentina |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Building Materials |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.5B |
| IPO Year | 2011 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PCRX | LOMA |
|---|---|---|
| Price | $26.26 | $12.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 2 |
| Target Price | ★ $32.86 | $15.00 |
| AVG Volume (30 Days) | ★ 687.5K | 548.6K |
| Earning Date | 11-06-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.47 | 0.06 |
| Revenue | ★ $716,791,000.00 | $464,306,268.00 |
| Revenue This Year | $6.24 | $22.92 |
| Revenue Next Year | $9.53 | $25.84 |
| P/E Ratio | ★ $55.72 | $212.05 |
| Revenue Growth | ★ 3.14 | N/A |
| 52 Week Low | $18.17 | $7.04 |
| 52 Week High | $27.64 | $14.17 |
Technical Indicators
Market Signals| Indicator | PCRX | LOMA |
|---|---|---|
| Relative Strength Index (RSI) | 72.55 | 66.02 |
| Support Level | $23.63 | $11.90 |
| Resistance Level | $24.81 | $13.14 |
| Average True Range (ATR) | 0.93 | 0.53 |
| MACD | 0.25 | -0.02 |
| Stochastic Oscillator | 100.00 | 82.74 |
Price Performance
Historical ComparisonAbout PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About LOMA Loma Negra Compania Industrial Argentina Sociedad Anonima ADS
Loma Negra Cia Industria Argentina SA is a cement producer in Argentina. The company operates in five segments: Cement, masonry cement, and lime; Concrete; Rail services; Aggregates; and Others. The majority of its revenue derives from Cement, masonry cement, and lime segments.